CKPT: Checkpoint Therapeutics Inc. Bozor kapitallashuvining daromadga nisbati

Checkpoint Therapeutics, Inc (CKPT) kompaniyasining korporativ logotipi

Checkpoint Therapeutics (CKPT) kuchli tadqiqot va ishlanmalar (R&D) markazini saqlab qolgan holda, aksiyalar opsion tizimi orqali yetakchi ekspertlarni jalb qilmoqda. Narx/savdo koeffitsienti baholash tendentsiyasini aks ettiradi va ushbu ko'rsatkich 9239.00 darajasida qolmoqda. Biotehnologik startap hamyonbop maqsadli terapiya usullarini joriy qilmoqda. Strategiya cosibelimab uchun ishlanmalarni ishlab chiqish xarajatlarini kamaytirishga asoslangan bo'lib, bu kompaniyaga teri saratoni uchun samarali davolashni raqobatbardosh narxda taklif qilish imkonini beradi.

CKPT Checkpoint Therapeutics, Inc. P/S multiplikatori (04.07.2022 - 07.06.2025)

Checkpoint Therapeutics, Inc (CKPT) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor narxi va tahlilchilarning maqsadli narxlari:
Aksiya kotirovkalari checkpointtx.com|CKPT - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor qiymati Checkpoint Therapeutics, Inc|CKPT - Korxona qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga sof aktivlar qiymati Checkpoint Therapeutics|CKPT - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati checkpointtx.com|CKPT - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Checkpoint Therapeutics|CKPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Checkpoint Therapeutics Inc|CKPT - Kompaniya qarzlari|Balans qiymatiga qarzlar Checkpoint Therapeutics, Inc|CKPT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Checkpoint Therapeutics|Shoshilinch likvidlik koeffitsiyenti checkpointtx.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
CKPT - Sof daromad|Kelajakdagi sof foyda Checkpoint Therapeutics|CKPT - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Checkpoint Therapeutics Inc.|CKPT - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Checkpoint Therapeutics, Inc|CKPT - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda Checkpoint Therapeutics|CKPT - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi checkpointtx.com|CKPT - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Checkpoint Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
CKPT - Daromad va sotish hajmi|Prognoz qilingan sotish hajmi checkpointtx.com|CKPT - Narxning daromadga nisbati|Kelajakdagi narxning daromadga nisbati Checkpoint Therapeutics, Inc
Kompaniyaning fundamental tahlili:CKPT - checkpointtx.com
Checkpoint Therapeutics Inc. brend mahsuloti

Checkpoint Therapeutics avtonom dori ishlab chiqish sikli doirasida faoliyat yuritadi, bunda tibbiy innovatsiyalarga bo'lgan talab biznesni global makroiqtisodiy zarbalarga chidamli qiladi. Sotuvlar nisbatidagi narx tendentsiyasini tahlil qilish orqali investor bozor kapitalizatsiyasining yillik sotuvlar hajmi nisbatini baholaydi, bu esa joriy daromad generatsiya qilish sur'atlariga asoslanib aktivning haddan tashqari qimmat baholanganligini yoki biznesning o'sish potentsialini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning daromadga nisbati beigene.com ONC|P/S multiplikatori HALO (Halozyme)|Bozor kapitallashuvining daromadga nisbati RVMD|Ascentage - P/S multiplikatori|Sotuvga nisbatan narx CG Oncology Therapeutics|URGN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati bicara.com|Narxning daromadga nisbati Personalis|P/S multiplikatori Erasca Inc|Narxning daromadga nisbati Delcath (DCTH)|YMAB: Narxning sotuvga nisbati|Narxning daromadga nisbati Aura Biosciences, Inc. AURA|Candel Therapeutics Inc. (CADL) - Sotuvga nisbatan narx|Accuray - P/S multiplikatori|Narx/daromad koeffitsiyenti SELLAS Life Sciences SLS|Actuate Therapeutics, Inc (ACTU) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CTOR|Kapitalizatsiyaning daromadga nisbati HURA|TARA (protaratx.com) - Kapitalizatsiyaning sotish hajmiga nisbati|Kapitalizatsiyaning daromadga nisbati FATE (Fate Therapeutics)|WHWK (aadibio.com) - Bozor kapitallashuvining daromadga nisbati|TScan Therapeutics, Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati CSBR (Champions Oncology Inc)|XBiotech USA - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati CVM (CEL-SCI Corporation)|OSTX: P/S multiplikatori|Sotuvga nisbatan narx radiopharmtheranostics.com (RADX)|Narxning daromadga nisbati Artiva Biotherapeutics Inc.|ANL: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori VERU|P/S multiplikatori tempesttx.com (TPST)|Narxning daromadga nisbati Xilio Therapeutics XLO|RENB (Renovaro Biosciences) - Narxning sotuvga nisbati|Mural Bio - P/S multiplikatori|Sotuvga nisbatan narx Kairos Pharma Ltd|OKUR (onkuretherapeutics.com) - Kapitalizatsiyaning daromadga nisbati|CytoMed Therapeutics Limited (GDTC) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati CRIS|APLM (Apollomics Corp) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori THAR|Narx/daromad koeffitsiyenti advanbiomed.com|P/S multiplikatori GNPX (Genprex, Inc.)|CLDI - Kapitalizatsiyaning daromadga nisbati|SBFM - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Xenetic Biosciences XBIO|SLRX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Kitov Pharma|Narxning daromadga nisbati American Oncology Network Inc|P/S multiplikatori beigene.com|Narxning daromadga nisbati Elevation Oncology (ELEV)|ICAD: Narxning sotuvga nisbati|Ikena Oncology - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati NTBL (Notable Labs Corp)|Viracta - P/S multiplikatori|morphosys.com (MOR) - Kapitalizatsiyaning daromadga nisbati|NAYA: P/S multiplikatori|Ascentage Pharma Group International (AAPGV) - P/S multiplikatori